Particle.news
Download on the App Store

CoreWeave Draws Split Wall Street Calls as Perplexity Deal Lands and Capex Jitters Persist

Investor debate centers on enormous 2026 capex that tests financing plans despite a massive backlog.

Overview

  • Oppenheimer initiated coverage with an Outperform rating and a $140 price target, arguing CoreWeave is well positioned for AI‑optimized infrastructure demand.
  • Bernstein began coverage at Underperform with a $56 target, and Jim Cramer told viewers he prefers NVIDIA over CoreWeave, adding pressure to the shares.
  • CoreWeave announced a multi-year partnership with Perplexity to power inference on dedicated GB200 NVL72 clusters, while adopting Perplexity’s Enterprise Max internally.
  • The company reported Q4 2025 revenue of $1.57 billion and full-year sales of about $5.1 billion with a $66.8 billion backlog, but posted a wider loss with EPS at -$0.89.
  • Management projected $30–$35 billion in 2026 capital spending and flagged heavy interest costs, as NVIDIA’s $2 billion January investment, insider stock sales, and new class-action filings sharpen governance scrutiny.